Marker Could Predict Dabrafenib Response in Melanoma

Researchers found that circulating cell-free DNA could represent a possible predictive marker of response in advanced melanoma patients treated with dabrafenib.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news